Literature DB >> 18384435

Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.

Yutaka Suehiro1, Yuji Hinoda.   

Abstract

Aberrant crypt foci (ACF) in colorectal mucosa are the earliest known morphological precursors to colorectal cancer and can be subclassified as dysplastic, heteroplastic (non-dysplastic), and mixed types. Serrated adenoma (SA) is a polyp with serrated architecture and dysplasia, and can be subclassified as traditional SA or sessile SA. Sessile SA is thought to be preneoplastic and differs from most lesions in the traditional SA category because of their flat morphology and general lack of cytological dysplasia. Serrated polyps include hyperplastic polyps (HP), SA, and admixed hyperplastic-adenomatous polyps and are considered a morphological continuum encompassing heteroplastic ACF, HP, admixed hyperplastic-adenomatous polyps, and SA. Recent studies have uncovered other developmental pathways including a heteroplastic ACF-HP/SA-carcinoma sequence and a heteroplastic ACF-adenoma-carcinoma sequence. Heteroplastic ACF histopathologically resemble HP and SA. Sporadic HP are usually present in the left colon, are small, and are considered benign. However, adenocarcinoma arising in the setting of colorectal HP or SA, especially in patients with hyperplastic polyposis, has been described. The relationship between heteroplastic ACF, HP, and colorectal cancer is less certain than that of dysplastic ACF. Here, we discuss the current understanding of genetic and epigenetic alterations in the development of colorectal cancer. Our goal is to provide a conceptual framework for understanding the heteroplastic ACF-HP/SA-carcinoma sequence.

Entities:  

Mesh:

Year:  2008        PMID: 18384435     DOI: 10.1111/j.1349-7006.2008.00784.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  9 in total

Review 1.  Serrated pathway: alternative route to colorectal cancer.

Authors:  Arpád V Patai; Béla Molnár; Zsolt Tulassay; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

2.  Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon.

Authors:  Agnieszka Anna Rawłuszko; Karolina Horbacka; Piotr Krokowicz; Paweł Piotr Jagodziński
Journal:  BMC Cancer       Date:  2011-12-19       Impact factor: 4.430

3.  LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia.

Authors:  Isabel Quintanilla; Maria Lopez-Cerón; Mireya Jimeno; Miriam Cuatrecasas; Jennifer Muñoz; Leticia Moreira; Sabela Carballal; Maria Liz Leoz; Jordi Camps; Antoni Castells; Maria Pellisé; Francesc Balaguer
Journal:  Clin Epigenetics       Date:  2014-11-10       Impact factor: 6.551

Review 4.  Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma-A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis.

Authors:  Veronika Skarkova; Vera Kralova; Barbora Vitovcova; Emil Rudolf
Journal:  Cells       Date:  2019-03-12       Impact factor: 6.600

5.  Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.

Authors:  Isabel Quintanilla; María López-Cerón; Mireya Jimeno; Miriam Cuatrecasas; Michel Zabalza; Leticia Moreira; Virginia Alonso; Cristina Rodríguez de Miguel; Jennifer Muñoz; Sergi Castellvi-Bel; Josep Llach; Antoni Castells; Francesc Balaguer; Jordi Camps; Maria Pellisé
Journal:  Clin Transl Gastroenterol       Date:  2019-06       Impact factor: 4.488

6.  Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat.

Authors:  Qing Lu; Bo Jiang; Chen Lin; Tao Shan
Journal:  J Exp Clin Cancer Res       Date:  2008-08-05

7.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

8.  Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.

Authors:  Agnieszka A Rawluszko; Katarzyna E Bujnicka; Karolina Horbacka; Piotr Krokowicz; Paweł P Jagodziński
Journal:  BMC Cancer       Date:  2013-11-06       Impact factor: 4.430

Review 9.  Colorectal polyp risk is linked to an elevated level of homocysteine.

Authors:  Manchun Sun; Manyi Sun; Li Zhang; Songli Shi
Journal:  Biosci Rep       Date:  2018-04-20       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.